Compounds of the current invention relate to rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms. More specifically, compounds of the current invention relate to C-25 carbamate derivatives of rifamycin having another functional group or pharmacophore covalently attached to this position through a carbamate linkage. The resulting compounds exert their antimicrobial activity through a dual-function mechanism and therefore exhibit reduced frequency of resistance.
当前发明的化合物涉及具有抗微
生物活性的
利福霉素衍
生物,包括针对耐药微
生物的活性。更具体地说,当前发明的化合物涉及
利福霉素的C-25
氨基甲酸酯衍
生物,通过
氨基甲酸酯键连接到该位置的另一个功能基团或药效团。由此产生的化合物通过双重功能机制发挥其抗微
生物活性,因此表现出较低的抗药性频率。